TEVA

Teva Pharmaceutical Industries Limited Q1 Earnings Summary

(RTTNews) - Below are the earnings highlights for Teva Pharmaceutical Industries Limited (TEVA):

Earnings: -$139 million in Q1 vs. -$220 million in the same period last year. EPS: -$0.12 in Q1 vs. -$0.20 in the same period last year. Excluding items, Teva Pharmaceutical Industries Limited reported adjusted earnings of $548 million or $0.48 per share for the period.

Analysts projected $0.51 per share Revenue: $3.82 billion in Q1 vs. $3.66 billion in the same period last year.

-Guidance: Full year EPS guidance: $2.20 - $2.50 Full year revenue guidance: $15.7 - $16.3 Bln

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

More Related Articles

Info icon

This data feed is not available at this time.

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.